USOR/Texas Oncology — Weslaco, Texas

USOR/Texas Oncology is a clinical research site located in Weslaco, Texas, United States 78596.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

USOR/Texas Oncology has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Endometrial Cancer, Recurrent or Progressive Endometrial Cancer, Follicular Lymphoma.

Sponsors: Genmab, Epizyme, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Weslaco

Browse all research sites in Texas · View every site in Weslaco

• University of Texas Rio Grande Valley
• University of Texas at Rio Grande Valley
• Texas Valley Clinical Research
• Texas Oncology-Weslaco
• Texas Oncology-Central South
• Valley Diab. & Endo Comp Ctr
• Research Site
• Pfizer Investigational Site
• MBX Biosciences Investigational Site
• South Texas Cancer Clinic
• Pulmonary and Sleep Center of the Valley
• UT Rio Grande Valley

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USOR/Texas Oncology?

USOR/Texas Oncology has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USOR/Texas Oncology conducted?

USOR/Texas Oncology has 2 clinical trials on record, with 1 currently active. Their work covers Endometrial Cancer, Recurrent or Progressive Endometrial Cancer, Follicular Lymphoma.

Is USOR/Texas Oncology accredited by Crixeo Clinical Trials?

USOR/Texas Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USOR/Texas Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.